CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Genesystem Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Genesystem Co Ltd
200-9, Techno 2-ro, Yuseong-gu
Phone: +82 428638551p:+82 428638551 Daejeon, 34028  South Korea Ticker: 363250363250
Business Summary
GeneSystem Co Ltd is a Korea-based company principally engaged in the development and manufacture of molecular diagnostic solutions. The Company is engaged in the development, manufacture and sale of platform based on molecular diagnosis. The Company develops and manufactures products such as molecular diagnosis systems, biochips, test kits, and reaction reagents, among others. The Company develops in vitro diagnostic technology through immunodiagnosis technology and molecular diagnosis technology.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
2835 In vitro and in vivo diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Yu JinSeo 54
Vice President, Director Sa CheolHong 66
Managing Director Won JaeLee 61
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 76 (As of 12/31/2023)
Outstanding Shares: 6,784,176 (As of 9/30/2024)
Shareholders: 10,974
Stock Exchange: KDQ
Fax Number: +82 428638553


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024